or
forgot password

    • cancer clinical trials in alabama

    • DNA Chip Based Prognosis of Lung Cancer
    University of Alabama
    Birmingham, Alabama
    Carcinoma, Non-Small-Cell Lung
    Investigation of Genetic Determinants of Capecitabine Toxicity
    University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Breast Cancer
    Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Brain and Central Nervous System Tumors, Neurotoxicity
    Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
    Providence Cancer Center at Providence Hospital
    Mobile, Alabama 36608
    Chemotherapeutic Agent Toxicity, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Pain, Peripheral Neuropathy, Primary Peritoneal Cavity Cancer
    Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Childhood Hepatoblastoma, Stage I Childhood Liver Cancer, Stage II Childhood Liver Cancer, Stage III Childhood Liver Cancer, Stage IV Childhood Liver Cancer
    Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy
    University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Breast Cancer
    Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
    Children's Hospital of Alabama at University of Alabama at Birmingham
    Birmingham, Alabama 35233
    Lymphoma, Lymphoproliferative Disorder
    A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Non-Hodgkin's Lymphoma
    Study Evaluating Two Dose Levels of Targretin Capsules in Patients With Refractory Cutaneous T-cell Lymphoma (CTCL)
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Refractory Cutaneous T-cell Lymphoma
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Providence Cancer Center at Providence Hospital
    Mobile, Alabama 36608
    Colorectal Cancer, Precancerous Condition
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Providence Hospital
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    University of South Alabama
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    Aspirin in Reducing Events in the Elderly
    The University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Functional Disability, Dementia, Heart Disease, Stroke, Cancer, Bleeding
    I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Breast Neoplasms, Breast Cancer, Breast Tumors
    Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Adrenocortical Carcinoma, Gastrointestinal Carcinoid Tumor, Kidney Cancer, Neuroblastoma, Retinoblastoma, Sarcoma
    Evaluation of Patients With Bulky GIST Using Sunitinib
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Tumor
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    The Kirklin Clinic at Acton Road
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Immunotherapy Study for Surgically Resected Pancreatic Cancer
    University of South Alabama
    Mobile, Alabama 36693
    Pancreatic Cancer
    A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
    University of Alabama Comprehensive Cancer Center University of Alabama
    Birmingham, Alabama 35294
    Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia
    Connect® MM- The Multiple Myeloma Disease Registry
    The Cancer Center of Huntsville

    Trial Locations
    The Cancer Center of Huntsville
    DCH Health System
    Multiple Myeloma
    Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Liver Cancer
    Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)
    Investigational Site Number 840306

    Trial Locations
    Investigational Site Number 840306
    Investigational Site Number 840207
    Investigational Site Number 840351
    Squamous Cell Lung Cancer
    An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
    Clearview Cancer Institute
    Huntsville, Alabama 35805
    Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin, Acute Myeloid Leukemia, Multiple Myeloma
    Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma
    Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Chronic GVHD
    Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
    DCH Cancer Treatment Center
    Tuscaloosa, Alabama 35401
    Peripheral T-cell Lymphoma
    Reducing Breast Cancer Recurrence With Weight Loss
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Breast Cancer, Overweight, Obesity
    A Phase 1 Study in Participants With Advanced Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Birmingham, Alabama 35294
    Advanced Cancer, Squamous Cell Carcinoma, Carcinoma, Squamous Cell of Head and Neck, Lung Squamous Cell Carcinoma Stage IV, Anal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung
    EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Carcinoma
    A Multi-center Clinical Trial of the Misago(TM) Self-Expanding Stent System for Superficial Femoral Artery
    University of Alabama
    Birmingham, Alabama
    Peripheral Vascular Disease
    Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
    University of Alabama Hospital
    Birmingham, Alabama 35294
    Sickle Cell Disease, Vaso-occlusive Crisis, Pain Crisis
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Kidney Cancer
    Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma
    Providence Hospital
    Mobile, Alabama 36608
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Solar Radiation-related Skin Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Childhood Cancer Survivor Study
    University of Alabama at Birmingham/Children's of Alabama
    Birmingham, Alabama 35294
    Cancer
    First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Acute Myelogenous Leukemia, Diffuse Large B-Cell Leukemia, Chronic Lymphocytic Leukemia, Follicular Lymphoma
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    UAB Comprehensive Cancer Center

    Trial Locations
    UAB Comprehensive Cancer Center
    University of South Alabama Mitchell Cancer Institute
    Breast Cancer
    Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed Trastuzumab
    University of Alabama at Birmingham/ Kirklin Clinic Univ AL - PI
    Birmingham, Alabama 35294-0006
    Metastatic Breast Cancer, Trastuzumab, BKM120, HER2+